Literature DB >> 2824036

Avarol-induced DNA strand breakage in vitro and in Friend erythroleukemia cells.

W E Müller1, D Sladić, R K Zahn, K H Bässler, N Dogović, H Gerner, M J Gasić, H C Schröder.   

Abstract

The hydroquinone-containing cytostatic compound avarol inhibits predominantly growth of those cell lines which have a low level of superoxide dismutase. The substrate of this enzyme, the superoxide anion, was found to be formed during the in vitro oxidation reaction of avarol to its semiquinone radical in the presence of oxygen. Under the same incubation conditions plasmid DNA (pBR322) was converted from the fully supercoiled circular form mainly to the nicked circular form, indicating that the compound causes primarily single-strand breaks. Using Friend erythroleukemia cells (FLC) it was found that avarol induces a dose-dependent DNA damage; the maximum number of DNA strand breaks was observed at 5 h after addition of the compound to the cells. Removal of avarol resulted in a rapid DNA rejoining with biphasic repair kinetics [first half-time, 8 min (90% of the breaks) and a second half-time, 40 min (10% of the breaks)]. When the degree of avarol-induced DNA damage in FLC was compared with the drug-caused inhibition of cell growth a close correlation was established. Avarol displayed no effect on dimethyl sulfoxide-induced erythrodifferentiation of FLC as determined by the benzidine reaction and by dot blot hybridization experiments. From incubation studies of FLC with [3H]avarol no hint was obtained for the formation of an adduct between DNA and the compound. The subcellular distribution of [3H]avarol was studied in liver cells after i.v. application of the compound. The predominant amount of the compound was present in the cytosolic fraction; little avarol was associated with plasma membranes, nuclei, and mitochondria. Using (a) oxidative phosphorylation and (b) oxygen uptake as parameters for mitochondria function, no effect of the compound on the activity of this organelle was determined. These results suggest that avarol forms superoxide anions (and in consequence possibly also hydroxyl radicals) especially in those cells which have low levels of superoxide dismutase. Moreover, evidence is provided that the active oxygen species cause DNA damage resulting in the observed cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824036

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro- and macroorganisms.

Authors:  Maria Tsoukatou; Jean Philippe Maréchal; Claire Hellio; Irena Novaković; Srdan Tufegdzic; Dusan Sladić; Miroslav J Gasić; Anthony S Clare; Constantinos Vagias; Vassilios Roussis
Journal:  Molecules       Date:  2007-05-15       Impact factor: 4.411

2.  A sesquiterpene quinone, dysidine, from the sponge Dysidea villosa, activates the insulin pathway through inhibition of PTPases.

Authors:  Yu Zhang; Yan Li; Yue-wei Guo; Hua-liang Jiang; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

Review 3.  Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida.

Authors:  Dusan Sladić; Miroslav J Gasić
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

4.  Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.

Authors:  Takushi Namba; Rika Kodama
Journal:  Mar Drugs       Date:  2015-04-16       Impact factor: 5.118

5.  Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone.

Authors:  Concetta Imperatore; Roberto Gimmelli; Marco Persico; Marcello Casertano; Alessandra Guidi; Fulvio Saccoccia; Giovina Ruberti; Paolo Luciano; Anna Aiello; Silvia Parapini; Sibel Avunduk; Nicoletta Basilico; Caterina Fattorusso; Marialuisa Menna
Journal:  Mar Drugs       Date:  2020-02-14       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.